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[57] ABSTRACT 
A method of improving the metabolic stability of neo 
natal pigs and increasing their survival rate by adminis 
tering to the pregnant sow during its latter stages of 
gestation up to about 80 days prior to parturition an 
effective amount of a material selected from the group 
consisting of a dihydroxy alkanol having 3 to 10 carbon 
atoms; a triglyceride of glycerol and fatty acids wherein 
at least one of the fatty acid moieties containing 8 to 12 
carbon atoms with the remaining acid moieties contain 
ing 13 to 20 carbon atoms; the mono and diol esters of 
said alkanols and said fatty acids wherein at least one of 
the fatty acid moieties contains 8 to 12 carbon atoms 
with the remaining acid moieties containing 13 to 20 
carbon atoms; and the ester of said dihydroxy alkanol 
and fatty acids containing 13 to 20 carbon atoms. 
8 Claims, No Drawings 
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METHOD FOR IMPROVING THE METABOLIC 
STABILITY AND SURVIVAL OF NEONATAL PIGS 
BACKGROUND AND SUMMARY OF THE 
INVENTION 
The present invention is a continuation-in-part of 
US. Ser. No. 107,886 ?led Dec. 28, 1979, now US. Pat. 
No. 4,329,359 which issued May 11, 1982. 
The present invention relates to an improved method 
for increasing the survival rate of baby pigs. More par 
ticularly, the present invention is directed to a method 
of increasing the survival rate of baby pigs by using a 
food supplement in the diet of a pregnant pig. 
The low survival rate observed in baby pigs, e.g., 20 
to 30% mortality between birth and weaning, is attrib 
uted largely to two factors: 
(1) the high degree of metabolic immaturity in the 
newborn pig and 
(2) an insufficient energy intake by the pig in its ?rst 
2 or 3 days of life. The magnitude of this loss can be 
emphasized by the fact that each 1% improvement in 
pig survival will generate an additional $2.00 to $6.00 
pro?t per litter. 
The major metabolic defects observed in the new 
born pig are summarized as follows: 
1. A low level of phosphorylase potentially decreases 
the rate of production of glucose from glycogen 
stores; ‘ 
2. A defective gluconeogenic capacity limits the sup 
ply of glucose available to animals exposed to nu 
tritional and/ or environmental stress; 
3. A de?cient hepatic mitochondria number limits the 
use of carbohydrates as well as fatty acids for en 
ergy production; 
4. A small amount of body fat impairs both thermoin 
sulation and the quantitative contribution of fat as a 
major energy source; and 
5. A low level of amino acid degradating enzymes 
tends to limit the availability of amino acids as a 
substrate source (carbon skeletons) for gluconeo 
genesis. 
More speci?cally, the high mortality rate observed in 
pigs is attributed largely to the newborn pigs impaired 
thermostability and defective gluconeogenic capacity 
and its inability to obtain a suf?cient energy intake from 
the sow’s milk during its ?rst 2 or 3 days of life. Because 
of these major metabolic defects, as well as the others 
set forth hereinabove, particularly its low gluconeo 
genic capacity, the neonatal pig rapidly develops hypo 
glycemia after birth if not permitted to suckle or if 
subject to cold stress. 
This rapid onset of hypoglycemia in the newborn pig 
is the result of 95% of the pig’s energy reserves in7 the 
form of glycogen being used within the ?rst 72 hours of 
birth regardless of whether the pig is suckled or not by 
the sow. The signi?cance of the baby pig’s susceptibility 
to hypoglycemia is indicated by the‘ 30 to 50% death 
loss observed within 72 hours after birth when baby 
pigs are fasted from birth or when baby pigs are fed for 
6 hours after birth and then fasted. 
Research has been conducted ‘to identify factors 
which would reduce baby pig mortality. These investi 
gations have suggested that the existence of physiolog 
ical conditions, i.e., diabetes, starvation, high dietary fat 
intake, etc., which are associated with elevated blood 
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ketone levels in the sow, may result in heavier, more 
metabolically stable pigs at birth. 
Accordingly, an object of the present invention is to 
provide an improved method for increasing the survival 
rate of baby pigs. 
A further object of the present invention is to provide 
a method for improving the metabolic stability of the 
newborn pig by preventing the development of hypo 
glyc'emia in the neonatal pig shortly after birth. 
Still another object of the present invention is to 
provide a food supplement which is effective in elevat 
ing the ketone levels in blood of the pregnant pig. 
A still further object of the present invention is to 
provide a food supplement which is effective in elevat 
ing the ketone levels in blood of the pregnant pig. 
Other objects and further scope of applicability of the 
present invention will become apparent from the de 
tailed description given hereinafter. However, it should 
be understood that the detailed description and speci?c 
examples, while indicating preferred embodiments of 
the invention, are given by way of illustration only, 
since various changes and modi?cations within the 
spirit and scope of the invention will become apparent 
to those skilled in the art from this detailed description. 
Pursuant to the present invention, it has been deter 
mined that the administration of speci?c alcohols, esters 
and glycerides to female pigs during late stages of gesta 
tion effectively increases the liver glycogen stores in the 
pig at birth and prolongs the availability of the liver 
glycogen stores in the newborn pig. This increased 
availability of glycogen delays the onset of hypoglyce 
mia in the pig and increases the survival rate (percent of 
pigs born alive that survive to weaning) of neonata 
plgS. . - 
The alcohols, esters and glycerides which can be 
effectively used in accordance with the present inven 
tion fall into the following categories: - 
1. Dihydroxy alkanols having 3 to 20 carbon atoms, 
such as for example 1,3-Butanediol. 
2. The mono- and diesters of the dihydroxy alkanols 
having 3 to 10 carbon atoms and fatty acids having 810 
20 carbon atoms wherein at least one of the fatty acid 
moieties contains 8 to 12 carbon atoms (medium chain 
length) with the remaining acid moiety. if any, con 
taining 13 to 20 carbon atoms (long chain length). 
Exemplary of such esters is 1,3-Butanediol monooc 
tanoate. \ 
3. A triglyceride of glycerol and fatty acids having 8 
to 20 carbon atoms wherein at least one of the fatty acid 
moieties contains 8 to 12 carbon atoms, with the remain 
ing acid moiety, if any, containing 13 to 20 carbon 
atoms. 
4. The mono- and diesters of dihydroxy alkanols 
having 3 to 10 carbon atoms and fatty acids containing 
13 to 20 carbon atoms. 
When considering the dihydroxy alkanols or esters 
thereof as a suitable additive, the hydroxy constituent 
must be on the first and third carbon atom to minimize 
any possible toxic effect. If the alkanols contain three or 
more OH groups, the additional OH groups above two 
are advantageously positioned on the odd carbon 
atoms. Also, in categories 2 and 3 above it is important 
that at least some medium chain fatty acid be present in 
the moiety. For example, the following differences in 
intestinal absorption and metabolism of medium chain 
triglycerides (MCT) and long chain triglyerides (LCT) 
are known to exist in mammals. 
1. MCT are absorbed and metabolized more rapidly 
than LCT. 
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2. The intestinal absorption of MCT does not require 
the presence of bile salts or pancreatic lipase; whereas, 
the absorption of LCT is entirely dependent on whether 
or not a sufficient quantity of bile salts and pancreatic 
lipase are present to emulsify and hydrolize the LCT. 
MCT may be absorbed intact and still be utilized by the 
animal because MCT may be completely hydrolyzed in 
the intestinal mucosal cell, whereas LCT cannot. 
3. The intestine has a greater capacity to absorb MCT 
compared with LCT. 
4. Fatty acids derived from MCT are transported to 
the liver for metabolism principally by the portal vein 
and not by the intestinal lymphatic system as are fatty 
acids from LCT. - 
5. Fatty acids derived from MCT are transported in a 
non-ester?ed form; whereas fatty acids from LCT are 
re-ester?ed following absorption and then form chylo 
microns. 
6. Medium chain fatty acids are more rapidly oxidized 
than those of long chain fatty acids by many tissues, 
including the liver, small intestine and the striated mus 
cle. 
7. In the liver, medium chain fatty acids are princi 
pally metabolized to CO2, acetate and ketones. In con 
trast, long chain fatty acids are principally metabolized 
to triglycerides with only a small portion of the fatty 
acids being converted to CO2 and ketones. Because of 
the preferential metabolism of medium chain fatty acids 
to CO2 and ketones, MCT are poorly utilized for tissue 
lipid synthesis; whereas, LCT are directly deposited as 
lipidin tissue. 
The rapid absorption and transportation of medium 
chain fatty acids to the liver and their preferential con 
version to ketones rather than triglycerides in tissue 
represent unique metabolic characteristics of MCT 
compared with LCT. In other words, although both 
' MCT and LCT are triglycerides of glycerol, MCT 
elicit a nutritional and physiological response in mam 
mals unique from those of LCT. 
, For the above reasons the presence of medium chain 
fatty acids in categories 2 and 3 are essential. However, 
once having established the necessity of the presence of 
medium chain fatty acids, there are also some additional 
advantages to be gained by the presence of some long 
chain fatty acids together with the medium chain fatty 
acids. Thus the presence of some long chain fatty acids 
provides the additional bene?ts of an increase in the 
milk fat content, a tendency to increase body fat content 
of the pigs at birth and a tendency to increase the total 
amount of colostrum produced by the sow. With re 
spect to category 4 above, since the dihydroxy alkanol 
portion of the ester provides the desired food supple 
ment advantages, a long chain fatty alone can be used in 
forming the ester. However, the presence of the long 
chain fatty acids together with the alkanol in forming 
the ester does enhance the antimicrobial activity and 
thus may increase the pig survival rate when compared 
to‘ the use of the dihydroxy alkanol alone. 
The alkanols and the glycerides are administered to 
the pregnant pig as a food supplement, for example, as 
an addition to a com-soybean meal diet. The alkanol 
supplement, for example, 1,3-Butanediol, which is a 
ketone former, has been found to be palatable and effi 
ciently utilized by the pig when included as a food 
supplement to provide about 2 to 20% of the dietary 
energy in the pigs diet as shown in the following table. 
If the food supplement is administered over longer peri 
ods of time, i.e., up to about 80 days prior to parturition, 
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then a smaller percentage of the dietary energy in the 
pig’s diet, for example about 2 to 10% or more prefera 
bly 4 to 8%, can be effectively provided. 
TABLE 1 
1,3-Butanediol Supt‘ ‘im- in Growing Swine 
1,3-Butanediol, % of dietary energy 
Trait 0 8 17 25 33 42 
Wt. gain, kg 19.5 20.5 21.4 11.9 4.3 1.1 
ME intake, Meal 197 212 219 157 85 77 
ME/wt gain, Meal/kg 10.1 10.3 10.2 13.2 19.8 70.0 
Plasma 
B——hydroxybutyrate, 159 415 457 425 831 980 
nmole/ml 
Acetoacetate, nmole/ml 69 100 115 183 150 198 
Glucose, mg/dl 75 72 95 97 142 119 
B. R. Romsos, P. S. Belo, E. R. Miller 8: G. A. Leveille, 1975 Journal of Nutrition, 
vol. 105, Page 16. ' 
As can be seen from the table, higher dietery levels of 
1,3-Butanediol, e.g., greater than 25% of ‘the dietary 
energy, tend to depress feed consumption and subse 
quent growth. 
Because ketones have shown to be readily transferred 
across the placenta, 1,3-Butanediol, a ketone former, 
represents a potential ‘supplemental’ energy source for 
the developing fetus. 1,3-Butanediol and its mono- and 
diesters have been shown to possess antimicrobial activ 
ity. Inclusion of antimicrobial agents in diets of pigs 
during late gestation and early lactation tends to in 
crease the survival rate of neonatal pigs. 
According to the present invention, it has been deter 
mined that a long-term administration of 1,3-Butanediol 
in sows during the latter stages of gestation results in an 
increased liver glycogen content in the newborn pig 
and an improved pig survival from birth to weaning. 
Advantageously, the administration of the speci?c food 
additive of the present invention can begin about 12 to 
80 days, advantageously about 20 to 40 days prior to 
parturition and continue until parturition, during which 
about 2 to 20%, advantageously 4 to 8% of the dietary 
energy of the ‘pig’s diet is provided. After parturition, 
the sows are allowed to consume a standard lactation 
diet. ' 
The following example is provided as being exem 
plary of the present invention and should not be consid 
ered as being limitative of the present invention. 
EXAMPLE 1 
Sixty-eight sows were fed isocaloric intakes (6800 
kcal of metabolizable energy/sow/day) of a forti?ed 
corn-soybean meal diet plus an additional 1700 kcal of 
metabolizable energy in the form of starch or 1,3 
Butanediol beginning approximately 8 days before par 
turition. After parturition, all sows were allowed to 
consume a standard lactation diet ad libitum. The results 
are shown in the following table: 
TABLE 2 
1,3-Butanediol Supplementation in Sows During Late Gestation.“ 
Prepartum Treatment“ 
Trait Control 1,3-Butanediol Change 
Pigs/litter 
At birth ' 10.39 10.14 
At weaning 8.79 9.28 +.49 
Avg. Pig Wt. 1kg! 
At birth 1.20 1.26 +.06 
At weaning 3.51 3.58 +08 
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TABLE 2-continued 
1,3-Butanediol Supplementation in Sows During Late Gestation.“ 
Prepartum Treatment” 
Trait Control 1,3-Butanediol Change 
Pig Survival, % 85.30 92.00 +6.7 
nThirty-eight and 40 litters represented in the control and 1,3-Butanediol treatments, 
respectively. 
As can be seen from the above table, the 1,3- 10 
Butanediol supplementation did not in?uence the num 
ber of live pigs born/litter (10.14 vs. 10.39) or the aver 
age pig weights (g) at birth (1,259 vs 1,205) or at wean 
ing (3575 vs 3510) compared to those of litters from 
sows fed starch. However, 1,3-Butanediol supplementa~ 
tion did increase the total number of pigs weaned/litter 
(9.28 vs 8.79) and the percent of pigs born alive (92.0 vs 
85.3) that survived to weaning compared to those of the 
starch treatment group. Sow feed intake and weight 
gain during lactation were not affected by dietary treat 
ment. 
In a second experiment, the addition of 1,3 
Butanediol to the diet of sows during late gestation was 
shown to increase the metabolic stability of the new 
born pig by increasing the level of liver glycogen pres 
ent in the pig at birth and delaying the onset of hypogly 
cemia in pigs which were allowed to nurse or were 
fasted from birth to 12 hr of age (Table 3). In addition, 
the colostrum of sows fed 1,3-Butanediol contained a 
higher percent fat than that of sows fed the control diet 
(Table 4). 
TABLE 3 
Effect on 1,3-Butanediol Supplementation in Sows During Late 
Gestation on Plasma Glucose and Liver Glycogen Stores 
in Neonatal Pigs.“ 
6 
TABLE 3-continued 
Effect on 1,3~Butanediol Supplementation in Sows During Late 
Gestation on Plasma Glucose and Liver Glycogen Stores 
in Neonatal Pigs.“ 
Age of Feeding Prepartum Treatment“ 
Pig, hr Regime Control 1,3-Butanediol 
12 Fasted 84.7 93.8 
"Thirty and 42 pigs represented in the control and 1,3-Butanediol treatments, 
respectively. 1 
TABLE 4 
Effect of 1,3-Butanediol Supplementation in Sows During Late 
Gestation on the Fat and Protein Content of Sow’s Colostrum.” 
Prepartum Treatment” 
Hr Postpartum Control 1,3-Butanediol 
Colostrum fat, % 
0 2.7 4.3 
12 3.1 3.9 
Colostrum protein, % 
0 13.8 15.1 
12 10.5 10.5 
‘Ten and fourteen samples represented in the control and 1,3-Butanediol treatments, 
respectively. 
EXAMPLE 2 
A varying number of sows as noted in Tables 5 and 6 
below were fed a forti?ed corn-soybean meal diet con 
taining as a food supplement an additional amount of 
30 metabolizable energy in the form of 1,3-Butanediol 
representing about 20% of the dietary energy in the 
sow’s diet. The sows were fed the butanediol for peri 
ods varying from 4 to 20 days prior to parturition and 
continuing until parturition. A number of similar runs 
35 were made in which the sows’ diet was not supple 
Age of Feeding mented with 1,3-Butanediol. The percentage survival of 
P18» hr Realms Control 1,3-B\"a"edi°1 the baby pigs where the diet of the sow was supple 
Liver glycogen, g mented with 1,3-Butanediol was compared with that 
0 -— 3.47 4.30 where no 1,3-Butanediol was administered. The results 
i; :“md ~70 ~35 40 are shown in the following tables wherein the results 
med '48 '96 recorded therein represent data recorded at 14 days 
Blood lucose, m d1 _ _ . . 
0 _ m 6 128 7 after birth in Table 5 and.28 days after blrth in Table 6. 
12 Nursed 92:7 124:2 The average improvement in pig survival for Tables 5 
and 6 is 6.38% and 10.8%, respectively. 
TABLE 5 
Days Adminis- 4 5 6 7 8 9 10 ll 
tered prior to 
Parturition ' 
No. of Sows 13 13 17 l9 l6 l0 8 9 
Observed 
% Survival of 75.0 85.9 78.4 86.2 80.2 91.9 79.9 71.9 
Baby Pigs w/o 
1,3-Butanediol 
N0. of Sows 18 13 l9 18 14 10 10 4 
Observed 
% Survival of 85.2 92.0 89.4 85.1 81.5 87.6 90.0 88.5 
Baby pigs with 
1,3-Butanediol 
% Gain or +102 +6.1 +11.0 -—1.1 +1.3 -4.3 +10.1 +16.6 
Loss 
Days Adminis- 12‘ l3 14 15 16 17 l8‘ 19' 20‘ 
tered prior to 
Parturition 
No. of Sows l 5 3 5 3 5 l 2 1 
Observed 
% Survival of 87.5 56.3 73.8 83.8 92.9 80.4 87.5 77.5 90.9 
Baby Pigs w/o 
1,3-Butanediol 
No. of Sows l 4 4 4 3 -_ 1 2 2 
Observed 
% Survival of 50.0 79.7 88.8 85.4 84.6 - 16.7 84.4 95.0 
Baby Pigs with 
4,423,072 
7 
TABLE 5-continued 
1,3-Butanediol 
% Gain or - I +23.4 +15.0 +1.6 —8.3 — -— -— — 
Loss 
Dilcounting the one and two sow observations (as noted by the ') as not being representative data and other observa 
tions where no data was recovered, the average improvement in percentage of pigs which survived was 6.38%. 
TABLE 6 
Days Adminis- 4 5 6 7 8 9 
tered prior to 
Parturition 
No. of Sows 
Observed 
% Survival of 
Baby Pigs w/o 
1,3-Butanediol 
No. of Sows 
Observed 
% Survival of 
Baby Pigs with 
1,3-Butanediol 
% Gain or 
Loss 
16 16 
73.6 78.0 90.0 
80.2 88.2 
+6.6 +7.6 — 1.8 
Days Adminis- 12' 
tered prior to 
Parturition 
No. of Sows l 4 3 5 2 3 
Observed 
% Survival of 
Baby Pigs w/o 
1,3-Butanediol 
No. of Sows 
Observed 
% Survival of 
Baby Pigs with 
1,3-Butanedib1 
% Gain or 
Loss‘v 
76.9 
— +21.6 +293 +4.7 
11 
64.2 80.0 
92.8 100.0 
+12.8 
18* 
87.5 
16.6 
19' 20* 
77.5 90.9 
84.4 95.0 
Discounting the one and two sow observations (as noted by the ') as not being representative data and other 
observations where no data wasrecovered, the average improvement in percentage of pigs which survived was 
1am. 
;What is claimed is: 
' 1. A method of improving the metabolic stability of 
neonatal pigs'and increasing their survival rate which 
comprises administering to a pregnant sow during its 
latterstages of gestation, up to about 80 days prior to 
parturition, an effective amount of a material selected 
from the group consisting of 1 
(l) a dihydroxy alkanol having 3 to 10 carbon atoms; 
(2) a triglyceride of glycerol and fatty acids wherein 
at least one of the fatty acid moieties contains 8 to 
12 carbon atoms with the remaining acid moieties 
containing 13 to 20 carbon atoms; 
(3) the mono and diol esters of said dihydroxy and 
said fatty acids wherein at least one of the fatty acid 
moieties contains 8 to 12 carbon atoms with the 
remaining acid moieties containing 13 to 20 carbon 
atoms; and 
(4) the ester of said dihydroxy alkanol and said fatty 
acids containing 13 to 20 carbon atoms. 
2. The method of claim 1 wherein the dihydroxy 
alkanol is 1,3-Butanediol. 
3. The method of claim 1 wherein the alkanol, the 
triglyceride or the mono and diol ester of said alkanols 
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and fatty acids are added as a food supplement to the 
sow’s diet. 
4. The method of claim 3 wherein the alkanol, the 
triglyceride or the mono and diol ester of said alkanols 
and fatty acids are added in an amount sufficient to 
provide about 2 to 20% of the dietary energy in the 
sow’s diet. 
5. The method of claim 1 wherein the alkanol, the 
triglyceride and the mono and diol esters of said alka 
nols and fatty acids are administered about 12 to 40 days 
before parturition and continued until parturition. 
6. The method of claim 1 wherein the monoester is 
1,3-Butanediol monooctanoate. 
7. The method of claim 1 wherein the alkanol, the 
triglyceride or the mono and diol ester of said alkanols 
and fatty acids are added in an amount sufficient to 
provide about 4 to 8%.by the dietary energy in the 
sow’s diet. 
8. The method of claim 1 wherein the OH groups of 
the dihydroxy alkanol are on the ?rst and third carbon 
atoms. 
1* 1t: It * t 
